Beam Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Beam Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Beam Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Beam Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 111k | 27.22 |
| 2023-09-30 | $3.0M | 125k | 24.05 |
| 2023-06-30 | $3.1M | 96k | 31.93 |
| 2023-03-31 | $2.4M | 78k | 30.62 |
| 2022-12-31 | $2.9M | 74k | 39.11 |
| 2022-09-30 | $2.8M | 58k | 47.60 |
| 2022-06-30 | $2.1M | 54k | 38.73 |
| 2022-03-31 | $2.6M | 45k | 57.26 |
| 2021-12-31 | $4.3M | 54k | 79.62 |
| 2021-09-30 | $17M | 200k | 87.01 |
| 2021-06-30 | $3.7M | 29k | 128.86 |
| 2021-03-31 | $1.9M | 24k | 80.10 |
| 2020-12-31 | $3.9M | 59k | 66.67 |
| 2020-09-30 | $368k | 8.8k | 41.67 |